Edwards Lifesciences Profit Margin 2010-2024 | EW

Current and historical gross margin, operating margin and net profit margin for Edwards Lifesciences (EW) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Edwards Lifesciences net profit margin as of June 30, 2024 is 24.55%.
Edwards Lifesciences Annual Profit Margins
Edwards Lifesciences Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $42.144B $6.005B
Edwards Lifesciences Corporation deals in products and technologies aimed at treating advanced cardiovascular diseases, especially structural heart disease in critically ill patients. The company is the world's leading manufacturer of tissue heart valves and repair products used to replace or repair a patient's diseased or defective heart valve. Edwards is also a leading player in hemodynamic monitoring systems used to measure a patient's cardiovascular function in the hospital setting. The company's products and technologies are categorized into four main areas: Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), Surgical Structural Heart, and Critical Care.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $234.954B 28.16
Intuitive Surgical (ISRG) United States $175.058B 99.12
Alcon (ALC) Switzerland $48.180B 33.92
IQVIA Holdings (IQV) United States $45.858B 25.99
IDEXX Laboratories (IDXX) United States $39.616B 47.66
DexCom (DXCM) United States $27.786B 39.62
STERIS (STE) Ireland $23.777B 27.74
SONOVA HOLDING (SONVY) Switzerland $20.808B 0.00
Waters (WAT) United States $20.560B 30.65
Hologic (HOLX) United States $18.870B 20.52
Sysmex ADR (SSMXY) Japan $12.134B 38.05
Teleflex (TFX) United States $11.552B 17.96
Fresenius Medical Care AG KGaA (FMS) Germany $11.379B 12.76
Globus Medical (GMED) United States $9.844B 27.54
Penumbra (PEN) United States $7.859B 81.58
Glaukos (GKOS) United States $7.357B 0.00
Masimo (MASI) United States $6.252B 33.48
TransMedics (TMDX) United States $5.606B 240.09
Integer Holdings (ITGR) United States $4.361B 25.50
PROCEPT BioRobotics (PRCT) United States $4.103B 0.00
Tandem Diabetes Care (TNDM) United States $2.848B 0.00
LivaNova (LIVN) United Kingdom $2.736B 16.05
Elekta AB (EKTAY) Sweden $2.601B 21.19
Inari Medical (NARI) United States $2.519B 0.00
Veracyte (VCYT) United States $2.423B 150.24
Nihon Kohden (NHNKY) Japan $2.287B 14.23
RxSight (RXST) United States $2.086B 0.00
Integra LifeSciences Holdings (IART) United States $1.578B 7.19
OPKO Health (OPK) United States $1.172B 0.00
Pulse Biosciences (PLSE) United States $1.142B 0.00
Artivion (AORT) United States $1.137B 104.38
AVANOS MEDICAL, INC (AVNS) United States $1.113B 19.85
Silk Road Medical (SILK) United States $1.102B 0.00
Alphatec Holdings (ATEC) United States $0.969B 0.00
OrthoPediatrics (KIDS) United States $0.774B 0.00
Mesa Laboratories (MLAB) United States $0.723B 18.26
Paragon 28 (FNA) United States $0.695B 0.00
SiBone (SIBN) United States $0.693B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.666B 0.00
IRadimed (IRMD) United States $0.595B 32.16
AxoGen (AXGN) United States $0.576B 0.00
Treace Medical Concepts (TMCI) United States $0.384B 0.00
Pacific Biosciences Of California (PACB) United States $0.373B 0.00
ClearPoint Neuro (CLPT) United States $0.358B 0.00
Sight Sciences (SGHT) United States $0.341B 0.00
Tactile Systems Technology (TCMD) United States $0.325B 9.92
Delcath Systems (DCTH) United States $0.306B 0.00
AngioDynamics (ANGO) United States $0.300B 0.00
Inogen (INGN) United States $0.291B 0.00
NeuroPace (NPCE) United States $0.231B 0.00
Nevro (NVRO) United States $0.231B 0.00
Accuray (ARAY) United States $0.216B 0.00
CVRx (CVRX) United States $0.215B 0.00
Semler Scientific (SMLR) United States $0.187B 13.09
Atossa Genetics (ATOS) United States $0.172B 0.00
Alpha Tau Medical (DRTS) Israel $0.171B 0.00
Spectral Diagnostics (EDTXF) Canada $0.141B 0.00
908 Devices (MASS) United States $0.137B 0.00
EDAP TMS S.A (EDAP) France $0.134B 0.00
KORU Medical Systems (KRMD) United States $0.116B 0.00
Sensus Healthcare (SRTS) United States $0.107B 15.90
Monogram Orthopaedics (MGRM) United States $0.087B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
EnVVeno Medical (NVNO) United States $0.070B 0.00
InspireMD (NSPR) Israel $0.069B 0.00
Envoy Medical (COCH) United States $0.059B 0.00
Covalon Technologies (CVALF) Canada $0.058B 0.00
T2 Biosystems (TTOO) United States $0.056B 0.00
LENSAR (LNSR) United States $0.054B 0.00
Accelerate Diagnostics (AXDX) United States $0.047B 0.00
Lucid Diagnostics (LUCD) United States $0.043B 0.00
Adagio Medical Holdings (ADGM) United States $0.039B 0.00
Vicarious Surgical (RBOT) United States $0.037B 0.00
Rapid Micro Biosystems (RPID) United States $0.036B 0.00
Precision Optics (POCI) United States $0.032B 0.00
ReWalk Robotics (LFWD) United States $0.030B 0.00
Neuronetics (STIM) United States $0.027B 0.00
Spectral AI (MDAI) United States $0.025B 0.00
DarioHealth (DRIO) United States $0.024B 0.00
Ekso Bionics Holdings (EKSO) United States $0.022B 0.00
Pixie Dust Technologies (PXDT) Japan $0.021B 0.00
NexGel (NXGL) United States $0.018B 0.00
Aspira Women's Health (AWH) United States $0.017B 0.00
Autonomix Medical (AMIX) United States $0.015B 0.00
QT Imaging Holdings (QTI) United States $0.015B 0.00
Microbot Medical (MBOT) United States $0.015B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.014B 0.00
Check-Cap (CHEK) Israel $0.011B 0.00
PAVmed (PAVM) United States $0.009B 0.00
ReShape Lifesciences (RSLS) United States $0.005B 0.00
Venus Concept (VERO) Canada $0.004B 0.00
Helius Medical Technologies (HSDT) United States $0.003B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nuwellis (NUWE) United States $0.002B 0.00
Tenon Medical (TNON) United States $0.002B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.001B 0.00
ENDRA Life Sciences (NDRA) United States $0.001B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00